Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of CO2 Enriched Ambient Air on Tobramycin Pharmacokinetics and Deposition in Bronchiectasis
2012-001541-40Phase 4Active
- Sponsor
- Vu University Medical Center
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tobramycin in bronchiectasis, sponsored by Vu University Medical Center. Primary endpoint: Mean clearance rate of 99mTc-DTPA. Started Jul 2012; status: active.
02
Drugs
tobramycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2012-001541-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001541-40.